en
Scientific article
Open access
English

Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects

Published inBMC neurology, vol. 15, 182
Publication date2015
Abstract

Dysferlin is reduced in patients with limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment myopathy, and in certain Ethnic clusters.

Citation (ISO format)
PETERSEN, Jens A et al. Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects. In: BMC neurology, 2015, vol. 15, p. 182. doi: 10.1186/s12883-015-0449-3
Main files (1)
Article (Accepted version)
Identifiers
ISSN of the journal1471-2377
452views
123downloads

Technical informations

Creation01/26/2016 10:49:00 AM
First validation01/26/2016 10:49:00 AM
Update time03/15/2023 12:23:02 AM
Status update03/15/2023 12:23:02 AM
Last indexation02/12/2024 11:24:51 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack